Notify me when PFIZER INC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ZURA | Zura Bio Limited | Class A Ordinary Shares, $0.0001 par value per share | 4.6% | $3,326,425 | 2,970,022 | Pfizer Inc. 13-5315170 | 31 Dec 2024 | ||
| CRDF | Cardiff Oncology, Inc. | Common Stock, $0.0001 par value per share | 3.6% | $5,739,548 | 2,411,575 | Pfizer Inc. 13-5315170 | 31 Dec 2024 | ||
| HLN | Haleon plc | Ordinary Shares, nominal value GBP0.01 per share | 0% | $0 | -$6,134,049,512 | 0 | -100% | Pfizer Inc. | 21 Mar 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|